Literature DB >> 23988764

Grading the severity of airways obstruction: new wine in new bottles.

Philip H Quanjer1, Jeffrey J Pretto, Danny J Brazzale, Piotr W Boros.   

Abstract

The objective of this study was to redesign the current grading of obstructive lung disease so that it is clinically relevant and free of biases related to age, height, sex and ethnic group. Spirometric records from 17 880 subjects (50.4% female) from hospitals in Australia and Poland, and 21 191 records (53.0% female) from two epidemiological studies (age range 18-95 years) were analysed. We adopted the American Thoracic Society(ATS)/European Respiratory Society (ERS) criteria for airways obstruction based on an forced expiratory volume in 1 s (FEV1)/(forced) vital capacity ((F)VC) ratio below the fifth percentile and graded the severity of pulmonary function impairment using z-scores for FEV1, which signify how many standard deviations a result is from the mean predicted value. Using the lower limit of normal for FEV1/(F)VC and z-scores for FEV1 of -2, -2.5, -3 and -4 to delineate severity grades of airflow limitation leads to close agreement with ATS/ERS severity classifications and removes age, sex and height related bias. The new classification system is simple, easily memorised and clinically valid. It retains previously established associations with clinical outcomes and avoids biases due to the use of per cent predicted FEV1. Combined with the Global Lung Function prediction equations it provides a worldwide diagnostic standard, free of bias due to age, height, sex and ethnic group.

Entities:  

Mesh:

Year:  2013        PMID: 23988764     DOI: 10.1183/09031936.00086313

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  40 in total

1.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

2.  Re-evaluation of the Uplift Clinical Trial Using Age-Appropriate Spirometric Criteria.

Authors:  Carlos A Vaz Fragoso; Linda S Leo-Summers; Thomas M Gill; Gail J McAvay
Journal:  Chest       Date:  2020-04-09       Impact factor: 9.410

3.  Spirometric Criteria for Chronic Obstructive Pulmonary Disease in Clinical Trials of Pharmacotherapy.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Linda S Leo-Summers; Peter H Van Ness
Journal:  COPD       Date:  2018-02       Impact factor: 2.409

4.  Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.

Authors:  William Checkley; Marilyn G Foreman; Surya P Bhatt; Mark T Dransfield; MeiLan Han; Nicola A Hanania; Nadia N Hansel; Elizabeth A Regan; Robert A Wise
Journal:  Respir Med       Date:  2015-11-11       Impact factor: 3.415

5.  Re-evaluation of combination therapy in chronic obstructive pulmonary disease (COPD).

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Linda S Leo-Summers; Peter H Van Ness
Journal:  Respir Med       Date:  2019-03-29       Impact factor: 3.415

Review 6.  Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) in Aging Populations.

Authors:  Carlos A Vaz Fragoso
Journal:  COPD       Date:  2015-12-02       Impact factor: 2.409

7.  Pre-hematopoietic stem cell transplant lung function and pulmonary complications in children.

Authors:  Ashok Srinivasan; Saumini Srinivasan; Sudeep Sunthankar; Anusha Sunkara; Guolian Kang; Dennis C Stokes; Wing Leung
Journal:  Ann Am Thorac Soc       Date:  2014-12

Review 8.  The diagnosis of chronic obstructive pulmonary disease.

Authors:  Rainer Burkhardt; Wulf Pankow
Journal:  Dtsch Arztebl Int       Date:  2014-12-05       Impact factor: 5.594

9.  FEV1 as a Standalone Spirometric Predictor and the Attributable Fraction for Death in Older Persons.

Authors:  Carlos A Vaz Fragoso; Peter H Van Ness; Gail J McAvay
Journal:  Respir Care       Date:  2019-10-29       Impact factor: 2.258

10.  Defining Airflow Obstruction.

Authors:  William L Eschenbacher
Journal:  Chronic Obstr Pulm Dis       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.